
Please don't tape your mouth at night, whatever TikTok says. A new study shows why this viral trend can be risky
A new review looks at the safety and effectiveness of mouth taping during sleep for conditions such as sleep apnoea. The news isn't so good.
You might have heard of people using tape to literally keep their mouths shut while they sleep. Mouth taping has become a popular trend on social media, with many fans claiming it helps improve sleep and overall health.
The purported benefits of mouth taping during sleep are largely anecdotal, and include claims of better airflow, less snoring, improved asthma symptoms, less dry mouth, being less likely to have bad breath, and better sleep quality.
As the trend has gained momentum in recent years, the claims have also come to include improved skin, mood and digestion – and even a sharper jawline.
The rationale for mouth taping during sleep is to encourage breathing through the nose rather than through the mouth. When a person's nasal passages are blocked, breathing switches from the nose to the mouth. Mouth breathing has been linked to conditions such as obstructive sleep apnoea. But is mouth taping an effective way to address these issues, and is it safe? A new review suggests taping your mouth shut while you sleep offers limited benefits – and could pose risks.
What did the review find?
In a new paper, Canadian researchers reviewed the scientific literature on mouth taping, searching for studies that mentioned terms such as 'mouth breathing', 'mouth taping' and 'sleep'.
They searched specifically for studies looking at people with known mouth breathing and breathing-related sleeping problems, such as obstructive sleep apnoea, to understand the potential benefits and harms of mouth taping for this group.
Obstructive sleep apnoea is a condition where your airway is partly or completely blocked at times while you're asleep. This can cause you to stop breathing for short periods, called 'apnoeas'. Apnoeas can happen many times a night, resulting in lowered oxygen levels in the blood as well as sleep disruption.
The researchers found ten eligible studies published between 1999 and 2024, with a total of 213 participants. Eight studies looked at mouth taping, and two studies involved using a chin strap to keep the mouth shut.
Only two studies identified any benefits of mouth taping for mild obstructive sleep apnoea. The observed improvements to measures such as oxygen levels in the blood and number of apnoeas per hour were modest. And although they were statistically significant, they were probably not clinically significant. This means these changes likely wouldn't make much difference to symptoms or treatment decisions.
The remainder of the studies found no evidence that mouth taping helps to treat mouth breathing or related conditions.
What's more, four studies warned about potential serious harms. In particular, covering the mouth could pose a risk of asphyxiation (lack of oxygen that can lead to unconsciousness or death) for people whose mouth breathing is caused by a significant blockage of the nasal airways. This kind of nasal obstruction could be a result of conditions such as hay fever, deviated septum, or enlarged tonsils.
In other words, mouth taping is definitely not a good idea if you have a blocked nose, as it's unsafe to have both the nose and the mouth obstructed at the same time during sleep.
What's the take-home message?
The authors concluded there are very few benefits and some potential serious risks associated with mouth taping in people who are mouth breathers or have obstructive sleep apnoea.
They did, however, note that we need further high-quality evidence to better understand if mouth taping is safe and works. This review didn't focus on any research relating to mouth taping for proposed improvements to mood, skin, digestion, sharper jaw lines and other things, so the researchers could not draw conclusions about the efficacy and safety of mouth taping for those purposes.
Internationally, qualified sleep health professionals do not recommend mouth taping.
If you have concerns about your sleep, the best thing to do is to consult trusted scientific sources or a healthcare professional who will be able to guide you to address the underlying causes of your sleep challenges.
Trying social media trends such as mouth taping before you seek expert advice could lead to delays in diagnosing serious conditions for which there are evidence-based treatments available. Mouth taping should definitely not be attempted in children.
It's possible that in some healthy adults, without respiratory conditions, without significant sleep disorders, and who don't have tape allergies, mouth taping could pose little harm and produce some modest benefits. But we don't have enough evidence yet to know one way or the other. DM

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Why $30,000 Invested This Way Makes Sense in Today's Market
Written by Andrew Walker at The Motley Fool Canada The TSX is at a record high, even as unemployment ticks up and recession risks rise. In these uncertain economic conditions Canadian investors are wondering where to allocate cash that is inside their self-directed Tax-Free Savings Account (TFSA) or Registered Retirement Savings Plan (RRSP) portfolio focused on income and long-term total returns. Guaranteed Investment Certificates (GICs) offer capital protection while providing a fixed return during the term of the certificate. As long as the GIC is purchased from a Canada Deposit Insurance Corporation (CDIC) member and is within the $100,000 limit, the government guarantees the funds in the event the issuing company goes bankrupt. GIC rates soared as high as 6% in late 2023, driven by aggressive interest rate hikes in Canada. Financial institutions set their GIC rates based on interest rates and yields on government bonds. GIC rates began to drop in 2024 as bond markets started to anticipate rate cuts. Those cuts arrived in the second half of last year and continued into the first part of 2025. Non-cashable GIC rates are currently available in the 3% to 3.75% range, depending on the issuer and the term. This is still comfortably above the current rate of inflation, so it makes sense for investors to hold some GICs in their portfolios. The downside of a non-cashable GIC is that the funds are unavailable during the term of the certificate. In addition, the rate paid is fixed for the term and the rates available for reinvestment when the GIC matures might be lower. Dividend stocks often provide better yields than the rates offered on GICs. This is due to the added risk of owning the stock. Share prices can fall below the purchase price and dividends are not 100% safe. The upside is that stocks offer more capital flexibility. Shares can be sold to immediately access funds that might be needed for an emergency or purchase. Additionally, dividend increases raise the yield on the initial investment. Enbridge (TSX:ENB) is a good example of a high-yield dividend stock that steadily raises the distribution. The board has increased the dividend annually for the past 30 years. Enbridge grows through acquisitions and development projects. The company spent US$14 billion in 2024 to buy three natural gas utilities in the United States. Enbridge is also working on a $28 billion capital program that will boost earnings over the next few years. The contributions from the new assets should support ongoing dividend growth. The right mix of GICs and dividend stocks for a portfolio is different for every investor, depending on risk tolerance, need for access to the capital, and the desired returns. In the current market, investors can quite easily put together a diversified portfolio of GICs and quality TSX dividend stocks to get an average return of at least 4%. That would provide annual income of $1,200 on a $30,000 portfolio while reducing risk and offering potential for some capital gains if stock prices rise. The post Why $30,000 Invested This Way Makes Sense in Today's Market appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Andrew Walker has no position in any stock mentioned. The Motley Fool recommends Enbridge. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
Big Comeback: This Big Bank Stock is Outperforming Its Peers
Written by Christopher Liew, CFA at The Motley Fool Canada Canada's banking sector is known globally as a bedrock of stability. The Big Banks, in particular, stand tall to this day despite economic downturns and financial crises. However, Toronto-Dominion Bank (TSX:TD) lost favour with investors last year. The country's second-largest financial institution pleaded guilty to violating the U.S. Bank Secrecy Act and paid a substantial fine of US$3 billion. Fast-forward to 2025, and the $166.6 billion bank looks stronger from the money laundering-related case. As of June 11, 2025, TD outperforms its Big Six peers as well as the broad market. The share price is $95.98, with a commanding year-to-date gain of plus-28.8% and a corresponding dividend yield of 4.4%. What is the reason for the big comeback? Has TD regained investors' confidence? Should you buy this large-cap stock now? TD never lost its handle on profitability despite a tarnished reputation in the financial markets. In Q2 fiscal 2025, net income climbed 334% to $11.1 billion compared to Q2 fiscal 2024. The Wholesale Banking segment reported a record $419 million in net income, a 16% jump compared to the same quarter last year. In the first half of the same fiscal year, the reported net income was $13.9 billion, a 158.3% increase from a year ago. Interestingly, TD's U.S. Retail Bank demonstrated resilience and delivered its sixth quarter of consumer deposit growth and double-digit growth. Raymond Chun, TD Bank Group's new President and CEO, said, 'TD delivered strong results this quarter, with robust trading and fee income in our markets-driven businesses as well as deposit and loan growth in Canadian Personal and Commercial Banking.' 'We are well-positioned as we enter the second half of the year,' he added. U.S. regulators imposed a cap on TD's US retail banking assets. The US$434 billion asset cap forms part of the penalty agreement with the Office of the Comptroller of the Currency (OCC). TD must downsize and comply with specific remedial actions before pursuing growth initiatives. The probationary period is five years. On February 10, 2025, TD announced the sale of its entire 10.1% stake in financial services firm Charles Schwab. Chun said, 'As part of our strategic review, we have been evaluating capital allocation and have made the decision to exit our Schwab investment.' TD intends to use a portion of the US$5.6 billion proceeds for share buybacks. The rest will be invested in businesses to boost performance and accelerate organic growth plans. Moreover, the private transaction provides the Canadian bank with a significant capital boost and liquidity flexibility. TD also realized a significant return on investment. Several factors contributed to TD regaining investors' confidence. First, the core Canadian personal and commercial banking segment delivered better-than-expected but solid revenue growth. Second, there is consistent progress on the Anti-Money Laundering (AML) remediation, according to Chun. Third, the broader positive sentiment in the financial sector, aided by lower interest rates, is another factor for the stock's surprise surge. Last, TD remains well-capitalized and has a sufficient buffer (14.3% CET1 ratio) against potential economic downturns. You can safely say that this Big Bank stock is back on investors' radars in 2025, primarily for income-seeking investors. The post Big Comeback: This Big Bank Stock is Outperforming Its Peers appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Charles Schwab is an advertising partner of Motley Fool Money. Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends Charles Schwab. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
Buy the Dip: 3 Canadian Stocks to Buy Even When Markets Fall
Written by Amy Legate-Wolfe at The Motley Fool Canada Market dips feel uncomfortable, but are often when the best long-term opportunities show up. While it's tempting to sit back and wait out the volatility, the smarter move is to keep a watchlist of high-quality stocks you'd love to own, especially when they go on sale. In Canada, three stocks stand out as top dip-buying candidates: Saputo (TSX:SAP), Boralex (TSX:BLX), and ATS (TSX:ATS). Each offers something different, but all share one thing in common: the potential to reward patient investors who are willing to act when prices slide. Saputo is one of the largest dairy processors in the world. It produces cheese, milk, and other dairy staples that Canadians use every day. That kind of built-in demand is one reason why the Canadian stock can be a safe place to land during volatile markets. In its most recent earnings report for the fourth quarter of fiscal 2024, Saputo posted revenue of $4.75 billion, up from $4.55 billion a year earlier. Net income came in at $74 million, down from $92 million, and earnings per share (EPS) dropped to $0.18 from $0.22. Even with the drop in profits, revenue growth stayed strong, proof that its products continue to sell, even when costs rise. As of now, the stock trades at around $30 and has gained over 10% year-to-date. That momentum makes it a solid defensive play if markets turn lower. Boralex is a renewable energy company, operating wind, solar, and hydroelectric power projects in Canada, the U.S., and Europe. The Canadian stock pulled back in recent months, making it an interesting buy-the-dip candidate. In the first quarter of 2025, Boralex reported net earnings of $41 million, down from $73 million a year ago. Revenue for the trailing 12 months came in at $822 million, with net income of $11 million. While earnings are down, Boralex is still actively expanding. It recently launched a new 106-megawatt wind farm in Scotland, which will begin generating income soon. Its long-term contracts with fixed prices help smooth out cash flow, and as the demand for green energy keeps growing, Boralex stands to benefit. The stock currently trades around $32, well below its 52-week high of $36.68, making it attractive for long-term investors who believe in the renewables story. ATS builds automation systems used in manufacturing across a range of industries, including life sciences, electric vehicles, and consumer products. It's a more growth-oriented stock than the others on this list, but it's also more volatile, making dips especially appealing. In its most recent earnings release for Q4 of fiscal 2025, ATS posted revenue of $721 million, down from $791 million the year before. The Canadian stock took a hit with a net loss of $68.9 million, tied to a one-time settlement with an electric vehicle (EV) customer. That hit pushed shares lower, but the Canadian stock's long-term prospects remain strong. Its backlog remains healthy, and it continues to land new business. Earlier this year, it reported Q3 earnings of $0.32 per share, down from $0.65, but revenue remained stable at $652 million. ATS trades near $44, down from its 52-week high, giving investors a chance to scoop it up at a discount while the short-term noise settles. Each of these Canadian stocks brings something different to the table. Saputo offers stability and a solid dividend. Boralex gives you exposure to the long-term growth of renewable energy. ATS is all about innovation and automation, with big upside once the macro picture improves. Together, these offer diversification across defensive, green, and growth sectors. Buying the dip doesn't mean buying blindly. But when quality companies stumble on short-term issues, it's worth taking a closer look. If markets fall again, these three names could be your chance to buy great businesses at better prices, and then enjoy the rebound that often comes next. The post Buy the Dip: 3 Canadian Stocks to Buy Even When Markets Fall appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends ATS Corp. The Motley Fool has a disclosure policy. 2025